title: Programmed death 1 is expressed in cutaneous infiltrates of mycosis fungoides and Sézary syndrome.
authors.affiliation: Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA.
authors.forename: David A
authors.initials: DA
authors.lastname: Wada
authors.forename: Ryan A
authors.initials: RA
authors.lastname: Wilcox
authors.forename: Susan M
authors.initials: SM
authors.lastname: Harrington
authors.forename: Eugene D
authors.initials: ED
authors.lastname: Kwon
authors.forename: Stephen M
authors.initials: SM
authors.lastname: Ansell
authors.forename: Nneka I
authors.initials: NI
authors.lastname: Comfere
mesh_terms: D015703:Antigens, CD / Q000032:analysis*; D051017:Apoptosis Regulatory Proteins / Q000032:analysis*; D016022:Case-Control Studies; D005434:Flow Cytometry; D006801:Humans; D007150:Immunohistochemistry; D009182:Mycosis Fungoides / Q000737:chemistry / Q000473:pathology*; D009363:Neoplasm Proteins / Q000032:analysis; D061026:Programmed Cell Death 1 Receptor; D012751:Sezary Syndrome / Q000737:chemistry / Q000473:pathology*; D012878:Skin Neoplasms; D013601:T-Lymphocytes / Q000737:chemistry / Q000473:pathology*
chemical_list: D015703:Antigens, CD; D051017:Apoptosis Regulatory Proteins; D009363:Neoplasm Proteins; C105992:PDCD1 protein, human; D061026:Programmed Cell Death 1 Receptor